Treating penile cancer
Your Questions Answered About Benign Prostatic Hyperplasia
An enlarged prostate—also known as benign prostatic hyperplasia (BPH)—is a natural sign of aging that affects half of all men over the age of 40. The good news is this condition does not increase your risk of developing prostate cancer. It can, however, disrupt your daily life by causing annoying and sometimes painful urination problems.
"Fortunately, for most patients, this condition is highly treatable and manageable with medical treatment," says Elisabeth Mulroy, MD, a urologist in the Division of Urology at University of Utah Health. "That's why it's good to recognize the symptoms and get help early on."
What's Happening Down There?BPH symptoms are caused by the prostate (a gland just beneath the bladder), compressing the urethra (the tube that lets urine leave the bladder and the body). As men age, the walnut-sized prostate grows, which can result in urinary problems.
Common symptoms of BPH include:
When symptoms arise, Mulroy encourages men to schedule a medical exam to explore underlying causes and treatment options. It's also important to discuss family history because genetics can be a risk factor for BPH.
"If symptoms go untreated, it can result in decreased quality of life and urinary tract infections," Mulroy says. "In more severe cases, it may result in urinary retention with the need for catheterization or possible kidney dysfunction."
What Are My Treatment Options?Your doctor may prescribe one or more types of medications, depending on your symptoms and the size of your prostate gland.
Common treatment options include:
As the old saying goes: An apple a day keeps the doctor away. Healthy living can significantly mitigate the effects of aging, including BPH. Here are some lifestyle changes that can help alleviate symptoms:
"It's so important to take care of ourselves as we age," Mulroy says. "A healthy lifestyle and annual health screenings can significantly improve health outcomes for men with BPH."
Know About These 8 Myths Associated With Benign Prostate Conditions
VERIFIED While some treatments for prostate conditions can impact sexual function, it is not inevitable. (Photo: Freepik) Did you know that not all prostate symptoms indicate a serious problem? Some urinary symptoms can be attributed to other factors, such as urinary tract infections or bladder issues.In the male reproductive system, the prostate is a small, walnut-sized gland that can become a topic of concern for men as they age. One often associates prostate-related problems with cancer, but benign prostate conditions -- such as benign prostatic hyperplasia (BPH) -- are common, and often misunderstood. Dr Niti Krishna Raizada, senior director, medical oncology and hemato-oncology at Fortis Hospitals, Richmond Road, Bangalore says there are numerous myths and misconceptions surrounding these conditions that can cause unnecessary anxiety and confusion.
The expert debunks some of the common myths surrounding benign prostate conditions; read on.
Myth 1: All prostate enlargement is cancerFact: This is one of the most prevalent myths. In reality, benign prostatic hyperplasia (BPH) is a non-cancerous condition characterised by the enlargement of the prostate gland. BPH is common among aging men and is not associated with an increased risk of prostate cancer. While BPH can cause urinary symptoms, it is not a malignancy.
Myth 2: Only older men experience benign prostate conditionsFact: While it is true that the risk of developing BPH increases with age, younger men can also be affected. Some men may experience symptoms of BPH in their 40s or even earlier. Although its prevalence rises with age, it is not exclusive to older individuals.
Myth 3: Benign prostate conditions don't require treatmentFact: Some men believe that benign prostate conditions do not require treatment, as they are non-cancerous. While these conditions are not life-threatening, they can significantly impact a man's quality of life. Symptoms such as urinary frequency, urgency, weak urine flow, and nocturia can be bothersome and disruptive. Treatment options are available to alleviate these symptoms.
Myth 4: Surgery is the only solutionFact: For BPH, there are various treatment approaches available. These range from lifestyle modifications to medications and minimally invasive procedures. Surgery is typically considered when other treatments have failed or in severe cases. Many men with BPH can effectively manage their symptoms without surgery.
Myth 5: Sexual dysfunction is inevitable with prostate conditionsFact: Many fear prostate conditions will lead to erectile dysfunction or reduced sexual desire. While some treatments for prostate conditions can impact sexual function, it is not inevitable. With appropriate management, most men can preserve their sexual health while addressing their prostate issues.
Myth 6: All prostate symptoms are a cause for concernFact: Not all prostate symptoms indicate a serious problem. Some urinary symptoms can be attributed to other factors, such as urinary tract infections or bladder issues. While it's essential to consult a healthcare provider when experiencing new or bothersome symptoms, not all of them are indicative of prostate conditions or cancer.
Myth 7: Prostate conditions are inevitableFact: While the risk increases with age, not all men will experience symptoms or require treatment for BPH. Maintaining a healthy lifestyle, including a balanced diet and regular exercise, can help reduce the risk and severity of these conditions.
Myth 8: Only medications can relieve prostate symptomsFact: While medications are commonly prescribed to alleviate BPH symptoms, there are other effective non-pharmacological approaches. Dietary modifications, exercise, and avoiding caffeine and alcohol can help improve urinary symptoms. Minimally invasive procedures and surgical options are also available for those who do not respond well to medication.
Benign Prostatic Hyperplasia Market Size In 7MM Is Expected To Witness A Major Change In The Study Period 2019–2032, Estimates DelveInsight
"The Benign Prostatic Hyperplasia market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period (2023-2032). Furthermore, launching various multiple- Benign Prostatic Hyperplasia pipeline products will significantly revolutionize the Benign Prostatic Hyperplasia market dynamics"The Benign Prostatic Hyperplasia market report provides current treatment practices, Benign Prostatic Hyperplasia emerging drugs, market share of individual therapies, and current and forecasted 7MM Benign Prostatic Hyperplasia market size from 2019 to 2032. The report also covers current Benign Prostatic Hyperplasia treatment market algorithms and unmet medical needs to curate the best opportunities and assess the market's underlying potential.
Key Takeaways from the Benign Prostatic Hyperplasia Market Research Report
Discover more about therapies set to grab major Benign Prostatic Hyperplasia Market Share @ Benign Prostatic Hyperplasia Market Size
Benign Prostatic Hyperplasia Overview
Benign prostatic hyperplasia—also called BPH—is a condition in men in which the prostate gland is enlarged and not cancerous. Benign prostatic hyperplasia is also called benign prostatic hypertrophy or benign prostatic obstruction. As the prostate enlarges, the gland presses against and pinches the urethra. The bladder wall becomes thicker. Eventually, the bladder may weaken and lose the ability to empty completely, leaving some urine in the bladder. The narrowing of the urethra and urinary retention—the inability to empty the bladder completely—cause many of the problems associated with benign prostatic hyperplasia.
Benign Prostatic Hyperplasia Epidemiology Segmentation in the 7MM
Download the report to understand which factors are driving Benign Prostatic Hyperplasia Epidemiology Trends @ Benign Prostatic Hyperplasia Epidemiological Insights
Benign Prostatic Hyperplasia Treatment Market
The Benign Prostatic Hyperplasia treatment includes watchful waiting, medical therapies, minimally invasive surgery, and surgery. Watchful waiting is the recommended strategy for patients with BPH who have mild symptoms and for those with moderate-to-severe symptoms who are not bothered by their symptoms and are not experiencing complications of BPH. Medical therapies for the treatment of BPH include alpha-blockers, phosphodiesterase-5 inhibitors, 5-alpha reductase inhibitors, and combination medications.
Benign Prostatic Hyperplasia Therapeutics Market
The key driver for the Benign Prostatic Hyperplasia market is an increase in the cases of risk factors such as obesity, heart and circulatory disease, type 2 diabetes, a rise in the geriatric population along with the expected approval of emerging therapies such as Vibegron (Urovant Sciences, DKF-313 (Dongkook Pharmaceutical), and others. The Benign Prostatic Hyperplasia pipeline brings a positive ray of hope for a better treatment pattern in the market in the upcoming years.
To know more about Benign Prostatic Hyperplasia Treatment options, visit @ Benign Prostatic Hyperplasia Drugs
Benign Prostatic Hyperplasia Market Insights
Vibegron by Urovant Sciences and DKF-313 by Dongkook Pharmaceutical are eagerly anticipated emerging Benign Prostatic Hyperplasia therapies pending approval. The limited Benign Prostatic Hyperplasia drug pipeline can be attributed to the condition's complex pathophysiology, rigorous regulations, established treatments, market competition, safety concerns, and prioritization of resources for more critical conditions. These challenges collectively contribute to the scarcity of new Benign Prostatic Hyperplasia treatments.
Benign Prostatic Hyperplasia Emerging Therapy Assessment
Pharmaceutical companies worldwide are dedicated to pioneering innovative Benign Prostatic Hyperplasia treatment approaches with a track record of significant progress. Prominent industry leaders, including Urovant Sciences, Dongkook Pharmaceutical, and others are actively engaged in the development of therapies to address Benign Prostatic Hyperplasia (BPH).
Learn more about the Benign Prostatic Hyperplasia Pipeline Therapies in clinical trials @ Benign Prostatic Hyperplasia Market Landscape
Scope of the Benign Prostatic Hyperplasia Market Research Report
Discover more about Benign Prostatic Hyperplasia Drugs in development @ Benign Prostatic Hyperplasia Ongoing Clinical Trials Analysis
Table of Content
To be continued in the report…
List of Top Selling Market Research Reports in 2023
Defibrillators MarketPulse Oximeters MarketAnterior Cruciate Ligament Injuries MarketImage Guided Surgery Devices MarketMalt Lymphoma MarketAge-related Macular Degeneration MarketCritical Limb Ischemia MarketAirway Stent Market MarketAngioedema MarketAutomated External Defibrillators MarketHelicobacter Pylori Infection MarketPolycythemia Vera MarketAdult Growth Hormone Deficiency MarketAnemia In Ckd MarketAsmd MarketBile Duct Neoplasm MarketHearing Implants MarketHelicobacter Pylori Infections MarketIntracranial Pressure Monitoring Devices MarketNeurostimulation Devices MarketPolycythemia MarketPrefilled Syringes MarketVascular Access Devices MarketBlood Glucose Monitoring Systems MarketBronchial Spasms MarketCardiac Resynchronization Therapy Device MarketChemotherapy-induced Peripheral Neuropathy MarketChronic Obstructive Pulmonary Disease Copd MarketDeep Vein Thrombosis MarketHemodynamic Monitoring Systems MarketNeurovascular Devices MarketOphthalmic Imaging Equipment MarketSurgical Stapling Devices MarketTreatment Resistant Depression Market
About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Healthcare Market Research Reports, Competitive Landscaping, and Mergers and acquisitions.
Contact Us
Yash Bhardwaj
info@delveinsight.Com
Comments
Post a Comment